首页 | 本学科首页   官方微博 | 高级检索  
检索        

利拉鲁肽对脲链佐菌素诱导阿尔茨海默病大鼠认知功能及Tau蛋白磷酸化的影响
引用本文:赵丽,王莉,莫玲,孙艳.利拉鲁肽对脲链佐菌素诱导阿尔茨海默病大鼠认知功能及Tau蛋白磷酸化的影响[J].癌变.畸变.突变,2021,33(4):280-285.
作者姓名:赵丽  王莉  莫玲  孙艳
作者单位:1. 哈尔滨医科大学公共卫生学院劳动卫生与环境卫生学教研室, 黑龙江 哈尔滨 150081;2. 哈尔滨医科大学附属第二医院老年病科, 黑龙江 哈尔滨 150001;3. 桂林医学院公共卫生学院, 广西 桂林 541199
基金项目:广西壮族自治区中青年教师基础能力提升项目(2021KY0511)
摘    要:目的:探讨利拉鲁肽对脲链佐菌素(STZ)诱导阿尔茨海默病(AD)大鼠认知功能及Tau蛋白磷酸化的影响。方法:Wistar雄性大鼠24只,随机分为空白对照组、假手术组、模型组和治疗组,每组6只,采用单次右侧脑室注射STZ(3 mg/kg)诱导AD大鼠,14 d后连续4周皮下注射利拉鲁肽干预;利用Morris水迷宫实验检测大鼠认知功能改变,利用免疫组织化学法和Western blot法检测Ser396位点磷酸化的Tau蛋白表达。结果:Morris水迷宫实验结果显示,与空白对照组相比,假手术组大鼠的逃逸潜伏期和穿越平台次数差异无统计学意义(P>0.05);与假手术组相比,模型组大鼠逃逸潜伏期和穿越平台次数增加(P<0.05);与模型组相比,利拉鲁肽治疗组大鼠逃逸潜伏期和穿越平台次数减少(P<0.05)。免疫组化和Western blot检测结果显示,模型组大鼠海马组织中Ser396位点磷酸化的Tau蛋白表达增加(P<0.05),经利拉鲁肽干预后表达减少(P<0.05)。结论:利拉鲁肽能改善STZ诱导的AD大鼠空间学习记忆能力的损伤,降低大鼠海马区Ser396位点磷酸化的Tau蛋白表达。

关 键 词:利拉鲁肽  脲链佐菌素  阿尔茨海默病  Tau蛋白磷酸化  
收稿时间:2021-04-19
修稿时间:2021-05-31

Effects of liraglutide on cognitive function and phosphor ylation of Tau protein in streptozotocin-induced Alzheimer in rats
ZHAO Li,WANG Li,MO Ling,SUN Yan.Effects of liraglutide on cognitive function and phosphor ylation of Tau protein in streptozotocin-induced Alzheimer in rats[J].Carcinogenesis,Teratogenesis and Mutagenesis,2021,33(4):280-285.
Authors:ZHAO Li  WANG Li  MO Ling  SUN Yan
Institution:1. Department of Labor Health and Environmental Hygiene, School of Public Health, Harbin Medical University, Harbin 150081;2. Department of Geriatrics, the Second Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang;3. School of Public Health, Guilin Medical University, Guilin 541199, Guangxi, China
Abstract:OBJECTIVE: To investigate effects of liraglutide on cognitive function and phosphorylation of Tau protein in a streptozotocin (STZ)-induced Alzheimer's disease (AD) in rats. METHODS: 24 male Wistar rats were randomly divided into blank control,sham operation,model and treatment groups,with 6 rats per group. For an AD rat model,each rat received a single injection of STZ (3 mg/kg) into the right intracerebroventricular region. After 14 days,rats in the treated group received subcutaneous injections of liraglutide for 4 weeks. Cognitive functions were detected using the Morris water maze test. Expressions of phosphorylation of Tau protein Ser396 were detected using immunohistochemistry (IHC) and Western blot methods. RESULTS: Results from the Morris water maze test show that both the escape latency and the number of times of crossing the platform for rats from the sham operation group were not significantly different from the blank control group (P>0.05). From the same test,results from the model rats were markedly increased over the sham operation group (P<0.05), that from the treated group were markedly decreased compared to the model group (P<0.05). Results from the IHC and Western blot analyses show that phosphorylations of the Tau protein Ser396 were increased significantly in the model rats (P<0.05) but decreased after liraglutide treatments (P<0.05). CONCLUSION: Our data show that liraglutide improved the STZ-induced damage of spatial learning and memory abilities and reduced expression of phosphorylation of Tau protein Ser396 in the hippocampi of rats.
Keywords:liraglutide  streptozotocin  Alzheimer's disease  Tau protein phosphorylation  
本文献已被 万方数据 等数据库收录!
点击此处可从《癌变.畸变.突变》浏览原始摘要信息
点击此处可从《癌变.畸变.突变》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号